4
Changes in Ownership
Avalyn Pharma Inc. Filed Acc 0001388325-26-000021
10% owner bought 555,555 shares at $18.00 ($9,999,990)
- 10% owner acquired 3,327,734 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S 10% owner | 2026-05-01 | Conversion | +3,327,734 | 3,327,734 | D | ||
| Novo Holdings A/S 10% owner | 2026-05-01 | Purchase | +555,555 | $18.00 | $9,999,990 | 3,883,289 | D |
| Derivatives | |||||||
| Novo Holdings A/S 10% owner | 2026-05-01 | Conversion · Series A Preferred Stock | −18,000,000 | 0 | D | ||
| Novo Holdings A/S 10% owner | 2026-05-01 | Conversion · Series B Preferred Stock | −1,986,369 | 0 | D | ||
| Novo Holdings A/S 10% owner | 2026-05-01 | Conversion · Series C-1 Preferred Stock | −25,899,284 | 0 | D | ||
| Novo Holdings A/S 10% owner | 2026-05-01 | Conversion · Series C-2 Preferred Stock | −5,587,603 | 0 | D | ||
| Novo Holdings A/S 10% owner | 2026-05-01 | Conversion · Series D Preferred Stock | −12,558,081 | 0 | D | ||
| Open-market purchases · 555,555 sh · avg $18.00 · $9,999,990 | |||||||
Loading xslF345X06/form4-05052026_040501.xml…